report the first-year outcomes of a 2-year, multicenter, parallel group, randomized, controlled trial to evaluate the efficacy and safety of twice-monthly versus daily oral risedronate for ...

抗骨松治疗药物主要包括： 双膦酸盐：如阿仑膦酸钠（Alendronate）和利塞膦酸钠（Risedronate），可以帮助减少骨吸收，增加骨密度。 钙和维生素 D ...

抗骨松治疗药物主要包括： 双膦酸盐：如阿仑膦酸钠（Alendronate）和利塞膦酸钠（Risedronate），可以帮助减少骨吸收，增加骨密度。 钙和维生素D补充 ...

Risedronate is the latest of the bisphosphonates to be used for the management of resorptive bone disease. Clinical improvements, assessed by the incidence of fracture and changes in bone mineral ...

Dosages of risedronate (up to 30 mg/day) are generally well tolerated by patients with osteoporosis or Paget's disease. Adverse events were reported by 92.1 and 92.8% of risedronate 5 mg/day and ...

While osteoporosis is much more common in adults over age 60, it can strike younger people too. In fact, according to the ...

All strategies reduce vertebral fracture risk, but only some of the reported compounds, including alendronate, risedronate and zolendronic acid have shown efficacy in the prevention of ...

Dear Savvy Senior, Can a person in their early fifties have osteoporosis? When I fell and broke my wrist last winter, the ...

Osteoporosis medications, such as bisphosphonates (for example, alendronate and risedronate), help slow bone loss and ...

The first line of treatment is usually bisphosphonates such as alendronate (Binosto and Fosamax), risedronate (Actonel and Atelvia) and ibandronate (Boniva). These oral or injectable drugs slow ...

Our NICE Advice service will guide you there. Get reliable scientific advice and NHS insights, direct from NICE. We support companies seeking nationwide adoption of the best treatments and care. Our ...